备注:
 如需更大包装,请联系销售人员,大包装有极大的折扣优惠!
          
       
       
       
       
        
        
详细介绍
 
       
              
          l  基本信息  | 
产品名称  | PA-824  | 
一般描述  | PA-824 is an anti-tuberculosis drug for tuberculosis with MIC less than 2.8 μM.  | 
别 称  | (6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine  | 
纯 度  | ≥98.0%(HPLC)  | CAS NO.  | 187235-37-6  | 
分子式  | C14H12F3N3O5  | 分子量  | 359.261  | 
适用范围  | 生物试剂,适用于细胞培养等  | 
l  理化信息  | 
外 观  | 固体  | 
溶解性(25°C)  | DMSO  | ≥50mg/ml  | 
乙醇  | ≥5mg/ml  | 
水  | Very slightly soluble  | 
l  生物学信息  | 
生物活性/药理作用  | Pretomanid is a nitroimidazole, a class of novel anti-bacterial agents. As a potential TB therapy, it has many attractive characteristics - most notably its novel mechanism of action, its activity in vitro against all tested drug-resistant clinical isolates, and its activity as both a potent bactericidal and a sterilizing agent in mice. In addition, the compound shows no evidence of mutagenicity in a standard battery of genotoxicity studies, no significant cytochrome P450 interactions, and no significant activity against a broad range of Gram-positive and Gram-negative bacteria.  | 
l  存储  | 
存储温度  | -20°C  | 
l  注意事项及免责声明  | 
本产品仅用于实验研究,不得作为药物使用,不得用于家用或其它用途。  | 
l  参考文献  | 
1.    http://www.drugbank.ca 2.    https://ncit.nci.nih.gov 3.    https://www.ncbi.nlm.nih.gov  |